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Summary: Two immunoinhibitory methods for measuring creatine kinase-MB (a dry chemical and a wet
chemical method) were compared with the commonly used agarose gel electrophoretic method, using 563
serum samples from 235 patients with suspected acute myocardial infarction. Comparison of the electrophoretic
and the dry chemistry methods showed the linear relationship: electrophoretic method = —6.5 U/l + 1.22 χ
dry chemistry method, r = 0.943. For the wet chemistry method the relationship was: electrophoretic method
= —7.2 U/l + 1.19 x wet chemistry method, r = 0.854. Parallel determinations of total creatine kinase were
also done and the methods were virtually identical in performance.
Compared with the electrophoretic method (which showed a 15% prevalence of acute myocardial infarction),
these classifications showed sensitivities of 0.92 and 0.67 and specificities of 0.94 and 0.99 (dry and wet
chemistry, respectively; using methods recommended by the manufacturers). After optimization of discrimi-
nators the sensitivity was increased to 0.94/0.92 and the specificity to 0.99/0.99.
Introduction .„ ., ,. . ,
specific antibodies against the subumt M. The anti-
Acute myocardial infarction is one of the commonest bodies have either been used in radioimmunoassays
causes of hospitalization and death in the western or for specific inhibition of the enzymatic activity of
industrialized countries. It is therefore of great im- the subunit M, followed by measurement of the re-
portance to have a fast, inexpensive, sensitive, and maining enzymatic activity (2, 5). The aim of this
specific diagnostic test. The most widely used single study is to compare two different immunoinhibition
laboratory test is electrophoretic determination of the methods (a dry and a wet chemistry method) with the
MB isoenzyme of creatine kinase (EC 2.7.3.2)1) (crea- commonly used but laborious electrophoretic method,
tine kinase-MB) (1, 2). This method is very specific
and reasonably sensitive, but it is rather tedious and
expensive (3, 4). The last decade has seen the devel- Materials and Methods
opment of easier analytical methods, which utilize Samples
The study included all consecutive serum samples taken for
creatine kinase-MB measurement at Glostrup Hospital during
!) Enzymes a two-month period: 563 serum samples from 235 patients (150
Adenylate kinase EC 2.7.4.3 men: mean age 59 years, range 19 — 90 years; 85 women: mean
Creatine kinase EC 2.7.3.2 age 65 years, range 31 —91 years).
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Measurement of total creat ine kinase and creatine
kinase-MB ac t iv i ty
Electrophoretic method
Total creatine kinase activity was measured on an LKB 8600
Rate Analyzer (LKB, Bromma, Sweden), according to the rec-
ommendations of the Scandinavian Committee on Enzymes
(SCE) (6, 7), using a reagent kit (CK NACactivated - Mono-
test — No. 126357) from Boehringer Mannheim (Mannheim,
W. Germany). Serum samples were diluted at total creatine
kinase activities above 1400 U/l. Relative creatine kinase-MB
activity was measured by fluorometry, using a Vitatron TLD
100 densitometer (Vitatron, Dieren, The Netherlands) after
electrophoretic separation on agarose gel film and reaction with
substrate (Creatine Phosphokinase Isoenzyme Substrate Set —
Coming, Halstead, UK) (2, 3). By this method the creatine
kinase is separated into the three main isoenzymes: creatine
kinase-MM, creatine kinase-MB, and creatine kinase-BB. The
total creatine kinase activity applied to the agarose gel film did
not exceed 1000 U/l (3). Creatine kinase-MB activity was cal-
culated by multiplying the relative creatine kinase-MB activity
by the total creatine kinase activity.
Dry chemistry method
Measurements were performed on an Ektachem 700 (Eastman
Kodak, Rochester, NY). Total creatine kinase activity was
measured using Clinical Chemistry Slides (CK — Generation
3) (8) from Eastman Kodak, calibrated against the SCE method
(6, 7). Serum samples were diluted at total creatine kinase
activities above 1600 U/l.
Creatine kinase-MB activity was measured using Clinical
Chemistry Slides (CK-MB — Generation 2) (9) from Eastman
Kodak, calibrated against the SCE method for measuring crea-
tine kinase-B subunit activity (5, 10). The creatine kinase-MB
activity is calculated as the measured creatine kinase-B subunit
activity multiplied by 2. Serum samples were diluted at creatine
kinase-MB activities above 300 U/l.
Wet chemistry method
Measurements were performed on a Cobas Mira (Hoffmann
La-Roche, Basel, Switzerland). Total creatine kinase was meas-
ured according to the SCE method (6, 7) using reagents from
Hoffmann La-Roche (CK N AC MA-KIT - No. 0713252),
following the protocol given by the manufacturer. Serum sam-
ples were diluted at total creatine kinase activities above 1000
U/l. Creatine kinase-MB was measured according to the SCE
method for measuring creatine kinase-B subunit activity (5, 10)
using reagents from Hoffman La-Roche (CK-MB MA-KIT —
No. 0720666). Serum samples were diluted at creatine kinase-
MB activities above 1000 U/l. Creatine kinase-MB activity was
corrected for interference from adenylate kinase1) (EC 2.7.4.3)
by subtracting the activity found before addition of creatine
phosphate, as recommended by Gerhardt & Waldenström (10).
Results below zero were given as zero. The creatine kinase-MB
activity was calculated as the measured creatine kinase-B sub-
unit activity multiplied by 2.
All dilutions were made using saline.
Detection l imi t
The detection limit was estimated as the mean of ten measure-
ments of the activity of a heat inactivated sample + 3 SD.
Diagnos t ic assessment
All serum samples from each patient were assessed as a group
and, if one sample from a patient complied with the criteria,
the patient was categorised as having acute myocardial
infarction. The criterion used for the electrophoretic method
was: creatine kinase-MB ^ 30 U/l (3). For the dry chemistry
method and wet chemistry method, two approaches were made:
A: Application of the criteria recommended for the individual
method:
Dry chemistry method:
total creatine kinase ^ 65 U/l,
creatine kinase-MB ^ 16 U/l, and
5% ^ creatine kinase-MB fraction < 24% (11)
Wet chemistry method:
total creatine kinase ^ 420 U/l,
creatine kinase-MB ^ 25 U/l, and
creatine kinase-MB fraction ^ 6% (according to manu-
facturer's recommendation)
B: Application of the criteria found by optimizing efficiency
(12) for the three discriminatory limits simultaneously:
The optimization of efficiency was performed for the following
range of discriminators: total creatine kinase > 50 — 400 U/l in
steps of 50 U/l, creatine kinase-MB ^ 10 — 40 U/l in steps of
5 U/l, and creatirie kinase-MB fraction ^0 — 7% in steps of
1%. The upper limit of creatine kinase-MB fraction was
maintained at 25%.
Estimation of infarct size
Finally the electrophoretic method and dry chemistry method
were used to estimate infarct size (13) in eight patients with
acute myocardial infarction. Creatine kinase-MB was measured
by both methods in 9 — 11 serum samples taken from each
patient over two days (about every four hours).
Stat is t ics
The statistics were computed with a STATGRAPHICS program
(STSC, Rockville, MD) for larger data series. Precision errors
were calculated by standard statistical procedures.
Deming regression was used to compare the methods (14, 15).
Only undiluted samples were used in the comparison, so as to
avoid bias due to dilution and skewness in weighting of extreme
values. This, however, resulted in different numbers of obser-
vations, because the dilution limits varied between the methods.
Results
Methodological assessment
Total creatine kinase
As shown in table 1, the precision of all three methods
is comparable. The three methods were highly cor-
related:
Electrophoretic method = 0.95 dry chemistry
method + 12 U/l
(n = 505, r = 0.994, SEE = 27 U/l).2)
Precision
Intra- and inter-assay precisions were estimated on a serum
sample analysed in duplicate in nine separate runs. The serum
sample was kept at — 80 °C until assayed.
2) n: number of observations
r: correlation coefficient
SD: standard deviation
SEE: standard error of estimate
n. s.: non significant
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Tab. 1. Intra- and inter-assay precision for total creatine kinase and creatine kinase-MB determinations estimated for serum
sample measured in duplicate in separate runs.
n
Intra-assay CV% 9
Inter-assay CV% 9
Creatine kinase (500 U/l)
Electro-
phoretic
method
1.8
2.3
Dry
chemistry
method
0.8
2.2
Wet
chemistry
method
1.2
2.0
Creatine kinase-MB (40 U/l)
Electro-
phoretic
method
4.3
7.8
Dry
chemistry
method
4.3
4.3
Wet
chemistry
method
3.5
7.7
n: Number of duplicate runs.
Electrophoretic method = 0.92 χ wet chemistry
method + 5 U/l
(n = 487, r = 0.996, SEE = 16 U/l).
The same linear relation was found when the diluted
samples were included (data not shown).
Using the heat-inactivated sample, the detection limit
was found to be 3.9 U/l for the wet chemistry method,
and below the lower limit of the manufacturer's fixed
measuring range of 1 U/l for the dry chemistry
method.
Creatine kinase-MB
As shown in table 1, the inter-assay precision of the
dry chemistry method was slightly better, whereas the
intra-assay precision of all three methods was com-
parable.
Figure 1 (a and b) compares the methods for meas-
uring creatine kinase-MB. Plots of the electrophoretic
method against the dry chemistry method and the wet
chemistry method show slopes significantly higher
than unity and intercepts significantly lower than
zero.
The correlation coefficient was found to be larger
(ρ ^ 0.001) and the SEE2) smaller for the dry chem-
istry method than for the wet chemistry method. The
same linear relation was found when the diluted sam-
ples were included (not shown). As noted in figure 1
two samples showed large deviations from the other
methods by the wet chemistry method. These results
were grave methodological errors as they could not
be reproduced by reanalysis.
Using the heat-inactivated sample, the detection limit
was found to be 6.6 U/l for the wet chemistry method
and below the lower limit of the manufacturer's fixed
measuring range of 1 U/l for the dry chemistry
method.
300
 Ί
Ο "05
Ο 100 200
Creatine kinase-MB
("dry chemistry" method) [U/l]
300
300η
200-
100-
100 200
Creatine kinase-MB
("wet chemistry" method) [U/l]
Fig. 1. Comparison of methods for determination of creatine kinase-MB by Detning regression.
Assessment performed on undiluted serum samples.
( ) Regression line, ( ) Identity line.
a: Electrophoretic method = 1.22 χ dry chemistry method —6.5 U/l (n =· 513, r = 0.943, SEE = 8.4 U/l)
b: Electrophoretic method = 1.19 χ wet chemistry method -7.2 U/l (n = 511, r = 0.854, SEE = 13.5 U/l).
In the calculation of regression b parameters, two results that deviated more than five SEE from the regression line were
excluded from the calculation (indicated by * in the figure).
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Creatine kinase-BB
The influence of creatine kinase-BB was investigated
in a random sample consisting of 199 serum samples
from 79 of the 235 patients. Fifteen (7%) of these
samples originating from 13 (10%) patients had crea-
tine kinase-BB ^ 5 U/l: 9.1 ± 2.6 U/l (mean ± SD).
However, this only resulted in an overestimation of
creatine kinase-MB of 5.3 + 7.2 U/l by the dry
chemistry method and of 7.9 ± 7.0 U/l by the wet
chemistry method.
A deny late kinase
In the presence of haemolysis equivalent to the release
of 50 mmol/1 haemoglobin, the erythrocyte-derived
adenylate kinase caused no significant interference in
the creatine kinase measurement by any of the three
procedures (data not shown).
Diagnostic assessment
Of the 235 patients, 36 were categorized by the elec-
trophoretic method as having acute myocardial in-
farction, which gives a prevalence of 15%. Compar-
ison of the dry chemistry method and wet chemistry
method with the electrophoretic method using ap-
proach A (tab. 2) showed that the dry chemistry
method and wet chemistry method were almost
equally efficient, but that the wet chemistry method
had a rather low sensitivity. Altogether 24 patients
were classified differently than by the electrophoretic
method. Three false negatives were found by the dry
chemistry method and the wet chemistry method,
because the creatine kinase-MB fraction was below
the given limits.
The false negatives found by the wet chemistry
method are chiefly explained by the high total creatine
kinase limit and creatine kinase-MB fraction limit.
The dry chemistry method showed 11 false positives.
In five cases the electrophoretic method and dry chem-
istry method yielded similar values, but indicated dif-
ferent diagnoses, because of the different discrimina-
tors of the two methods. Five more had increased
values, owing to interference from creatine kinase-BB
or macro creatine kinase, and in one the cause was
analytical error (found to be normal on re-analysis).
The optimal discriminators found by approach B for
the dry chemistry method were: total creatine kinase
^ 100 U/l, creatine kinase-MB ^ 25 U/l and 4% ^
creatine kinase-MB fraction ^ 25%; and for the wet
chemistry method: total creatine kinase ^ 350 U/l,
creatine kinase-MB ^ 35 U/l and 4% ^ creatine
kinase-MB fraction ^ 25%. Approach B clearly
showed better performance characteristics (tab. 2)
than did approach A, as only three patients were
classified differently by the electrophoretic and the
dry chemistry methods, only four by the
electrophoretic and the wet chemistry methods.
Estimation of infarct size
Infarct size was estimated from the area under the
curve of serum creatine kinase-MB as a function of
time. Comparison of estimated infarct size by the dry
chemistry and electrophoretic methods showed the
relationship: electrophoretic method =1.25 χ dry
chemistry method +1.4 (n.s.) for 8 patients giving
r = 0.992 and relative SEE of 9%.
Discussion
When the present data are compared with those re-
ported in earlier assessments of the immunoinhibition
methods and the electrophoretic method, details of
reagent composition, sample volume, and tempera-
ture are of paramount importance (1, 2, 6, 7). These
Tab. 2. Assessment of immunoinhibition methods in the diagnosis of acute myocardial infarction as established by the electro-
phoretic method:
Approach A Approach B
Electrophoretic pos.
method neg.
Sensitivity
Specificity
Predictive value pos.
Predictive value neg.
Efficiency
Dry
neg.
3
188
chemistry
0.92
0.94
0.75
0.98
0.94
method
pos.
33
11
Wet
neg.
12
198
chemistry
0.67
0.99
0.96
0.94
0.95
method
pos.
24
1
Dry chemistry
neg.
2
198
0.94
0.99
0.97
0.99
0.99
method
pos.
34
1
Wet chemistry method
neg.
3
198
0.92
0.99
0.97
0.98
0.98
pos.
33
1
Assessment on 235 patients, 36 of whom had acute myocardial infarction according to the electrophoretic method, which was
equivalent to a prevalence of 15%.
J. Clin. Chem. Clin. Biochem. / Vol. 28, 1990 / No. 7
Hadberg et al.: Creatine kinase-MB measured by immunoinhibition 457
parameters influence the purely methodological com-
parison, because they affect the slopes, and they also
influence the diagnostic assessment, because the dis-
criminators might change.
The technical performance of the three total creatine
kinase methods is good and the precisions are ac-
ceptable. The larger SEE for the dry chemistry
method can probably be ascribed to a higher sensitiv-
ity to matrix effects (16). The precision for creatine
kinase-MB is consistent with earlier investigations (3,
5, 10, 11, 17). The detection limits for the wet chem-
istry methods were rather high, especially for creatine
kinase-MB. This was partly due to the correction for
a negative adenylate kinase activity, but the mean
creatine kinase-MB activity alone was 3.4 U/l, giving
a detection limit of 4.9 U/l. When measured by the
dry chemistry method the heat-inactivated sample
gave activities below the lower limit of the manufac-
turer's fixed measuring range of 1 U/l.
As seen in figure 1 (a and b), both the dry chemistry
method and the wet chemistry method gave lower
values for high activity samples and higher values for
low activity samples, as compared with the electro-
phoretic method (17, 18).
This phenomenon is probably caused by two different
factors. It is well-known that in the electrophoretic
method the fluorescence at higher intensity is
quenched (2, 11). As the creatine kinase-MM fraction
is always greater than the creatine kinase-MB fraction
this will cause overestimation of creatine kinase-MB
activity (11). On the other hand, the immunoinhibi-
tion assays may overestimate creatine kinase-MB ac-
tivity in some low activity samples, owing to interfer-
ence from even small amounts of creatine kinase-BB
and macro creatine kinase activity in this activity
range (5, 19).
The number of samples showing creatine kinase-BB
activity was larger than reported earlier (19), possibly
because of differences in sample handling, as creatine
kinase-BB activity is quickly inactivated at room tem-
perature (19). This might also explain the discrepancy
between the estimate of creatine kinase-BB activity
found by electrophoresis and that found by the im-
munoinhibition methods, as these were performed
after the electrophoretic separation was started. The
possibility, however, that fluorescent substances in-
terfered (1, 2) cannot be ruled out, as a control in-
cubation without creatine phosphate was not per-
formed.
The accuracy of the methods was estimated by com-
parison with the electrophoretic method; various lyo-
philized materials with assigned values were inappro-
priate for analysis by the dry chemistry method, be-
cause their viscosity differed from that of serum (16).
The diagnosis of acute myocardial infarction is based
on three criteria: pathological electrocardiographic
changes, acute chest pain, and increased creatine ki-
nase-MB activity. We chose to assess the new immu-
noinhibition methods against the electrophoretic
method alone, because it is well established as the
optimal single diagnostic test in patients with sus-
pected acute myocardial infarction (20, 21).
We found that when we applied the manufacturer's
diagnostic criteria, the dry chemistry method gave too
many false positives and the wet chemistry method
too many false negatives. The acceptable balance be-
tween high sensitivity and high specificity will always
depend on the population involved (12). Because of
the severity of the disease, high sensitivity is preferable
to high specificity.
We found that the creatine kinase-MB limit for the
dry chemistry method could be raised to 25 U/l with-
out misclassifying more than one patient with acute
myocardial infarction. The reason for the low creatine
kinase-MB limit might be the use of single samples
in earlier assessments. We used the information gath-
ered from a series of samples from each patient sus-
pected of acute myocardial infarction.
The wet chemistry method gave too many false neg-
atives, mainly because of the very high total creatine
kinase limit recommended by the manufacturer, which
is higher than other recommendations (5, 22). The
creatine kinase-MB fraction limit should also be low-
ered. The value of 6% (22) is probably based on older
methods, either with activators other than N-acetyl
cysteine (NAC) or without correction for interference
from adenylate kinase (5, 10).
The optimal discriminators found for the two im-
munoinhibitory methods were rather different. The
main reason for the high values for the wet chemistry
method were a few samples from patients categorized
as having no myocardial infarction, with creatine
kinase-MB activities in the range of 25 — 50 U/l. A
change of the creatine kinase-MB discriminator to 25
U/l thus only reduced the specificity to 0.98. The
creatine kinase discriminator could be changed si-
multaneously to 100-200 U/l without affecting the
specificity further. For the dry chemistry method a
change of the creatine kinase discriminator to 300 U/l
showed unchanged efficiency, but a sensitivity of 0.92
and a specificity of 1.0.
Application of the lower creatine kinase-MB fraction
limit, with a view to eliminating false positive results
arising from either incomplete inhibition of creatine
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kinase-MM activity (5) or creatine kinase-MB activity
from skeletal muscle damage (1, 4), has been discussed
by others (10, 23). The disadvantage is that an acute
myocardial infarction could be masked by a simul-
taneous major release of creatine kinase-MM from
non-myocardial sources.
We have earlier shown that the electrophoretic
method may be used to estimate infarct size (13). Our
data clearly demonstrate that similar results would be
obtained with the dry chemistry method. From the
present study it can be concluded that the immunoin-
hibition methods possess performance characteristics
comparable to those of the well-known electropho-
retic method. The chief advantages are ease of use
and speed. The chief disadvantage is the lack of spec-
ificity against creatine kinase-BB and macro creatine
kinase which, however, seems to be a minor problem.
The use of optimized discriminators is, however, rec-
ommended for a given patient population, because
the efficiency optimization is only valid for popula-
tions with a similar disease prevalence.
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